| Financial Year |
March 31 2023 |
| Monetary Funds |
1,116,743,274.42 |
| Held-for-trading Financial Assets |
100,066,666.67 |
| Notes Receivable |
14,710,579.16 |
| Accounts Receivable |
621,390,370.80 |
| Advances to Suppliers |
60,856,511.72 |
| Other Receivables |
48,491,921.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
376,297,514.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,102,285.20 |
| Total Current Assets |
2,396,324,149.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
192,205,071.00 |
| Investment Properties |
201,469,017.85 |
| Fixed Assetes |
952,078,486.69 |
| Under-construction Projects |
96,284,015.94 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
742,093,458.95 |
| R&D expenses |
1,248,104,460.43 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,258,060.16 |
| Deferred Income Tax Assets |
127,949,619.25 |
| Other Non-Current Assets |
226,805,976.91 |
| Sub-Total of Non-Current Assets |
4,082,831,288.55 |
| Total Assets |
6,479,155,437.62 |
| Short-Term Loans |
483,660,250.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
178,357,616.19 |
| Accounts Received In Advance |
1,189,084.79 |
| Employee Compensation Payable |
62,224,974.17 |
| Taxes Payable |
19,722,743.82 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
76,629,538.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
383,773,314.07 |
| Other Current Liabilities |
177,713,781.19 |
| Sub-Total of Current Liabilities |
1,403,269,133.84 |
| Long-term Loans |
946,991,073.33 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
605,131.19 |
| Other Non-Current Liabilities |
8,589,625.00 |
| Sub-Total of Non-Current Liabilities |
1,062,816,168.38 |
| Total Liabilities |
2,466,085,302.22 |
| Paid-In Capital(Or Share Stock) |
1,114,117,970.00 |
| Capital Surplus |
847,575,154.49 |
| Surplus Reserve |
366,364,848.85 |
| LESS:Treasury Stock |
16,277,814.63 |
| Undistributed Profits |
1,469,731,999.38 |
| Minority Stockholder's Interest |
96,344,115.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,916,726,019.63 |
| Owner's Equity（Stockholder's Equity） |
4,013,070,135.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,479,155,437.62 |
